top of page

Publications
"Leaving the decision step to me": School Naloxone Policies Developed and Implemented by District and School Nurses
It's not in stock: Community pharmacists' decision-making and communication when refusing to dispense controlled substance prescriptions
Increasing Buprenorphine and Naloxone Access in Texas Community Pharmacies Through an Academic Detailing Intervention
How Do We Increase Treatment for Alcohol Use Disorder in Primary Care? It Takes a Team
Addressing wholesale distributor barriers to buprenorphine access: Consensus recommendations from the PhARM-OUD expert panel
Buprenorphine Adherence Trajectories and Their Impact on Opioid Overdose and Healthcare Costs
Prediction of Antipsychotic Associated Weight Gain in Children and Adolescents Taking Second Generation Antipsychotics: A Machine Learning Approach
Gaps in buprenorphine access: Examining provider availability and treatment continuity
Abolfazl Sadeghi, J. Douglas Thornton, Tyler J. Varisco
In Support of a Public Health Approach to Drug Policy: Position Statement of AMERSA, Inc
bottom of page
